Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell‐dominant allergic airway inflammation through delivery of miR‐146a‐5p
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Group 2 innate lymphoid cells (ILC2s) are recently reported to play a more critical role in allergic diseases. We previously identified that mesenchymal stromal cells (MSCs) elicited therapeutic effects on allergic airway inflammation. Small extracellular vesicles (sEV) derived from MSCs possess striking advantages including low immunogenicity and high biosafety, and is extremely promising cell‐free therapeutic agents. However, the effects of MSC‐sEV on ILC2s are still unclear. Additionally, scalable isolation protocols are required for the mass production of homogenous MSC‐sEV especially in clinical application. We previously reported that induced pluripotent stem cells‐derived MSCs were the ideal cellular source for the large preparation of MSC‐sEV. Here we developed a standardized scalable protocol of anion‐exchange chromatography for isolation of MSC‐sEV, and investigated the effects of MSC‐sEV on ILC2 function from patients with allergic rhinitis and in a mouse ILC2‐dominant asthma model. The characterization of MSC‐sEV was successfully demonstrated in terms of size, morphology and specific markers. Using flow cytometry and human Cytokine Antibody Array, MSC‐sEV but not fibroblasts‐sEV (Fb‐sEV) were found to significantly inhibit the function of human ILC2s. Similarly, systemic administration of MSC‐sEV but not Fb‐sEV exhibited an inhibition of ILC2 levels, inflammatory cell infiltration and mucus production in the lung, a reduction in levels of T helper 2 cytokines, and alleviation of airway hyperresponsiveness in a mouse model of asthma. Using RNA sequencing, miR‐146a‐5p was selected as the candidate to mediate the above effects of MSC‐sEV. We next revealed the uptake of ILC2s to MSC‐sEV, and that transfer of miR‐146a‐5p in MSC‐sEV to ILC2s in part contributed to the effects of MSC‐sEV on ILC2s in vitro and in a mouse model. In conclusion, we demonstrated that MSC‐sEV were able to prevent ILC2‐dominant allergic airway inflammation at least partially through miR‐146a‐5p, suggesting that MSC‐sEV could be a novel cell‐free strategy for the treatment of allergic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“anion-exchange chromatography method for purification of exosomes derived from iPSC-MSCs, which are termed as small extracellular vesicles (sEV) according to MISEV 2018 [26].”
MethodSelf-citationIsolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162152 · Cited by 1,133 · cited 1×
“PE, Ly-6G-Alexa 700 and Siglec-F-Alexa 647 and analysed based on gating strategies as previously reported (Supplementary figure 4 (a)) [30].”
Method
Cited by
Xiao, X., Xu, M., Yu, H., Wang, L., Li, X., Rak, J., Wang, S., & Zhao, R. C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00765-3 · Cited by 287
Zhu, Z.-H., Jia, F., Ahmed, W., Zhang, G.-L., Wang, H., Lin, C.-Q., Chen, W.-H., & Chen, L.-K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.346466 · Cited by 132
Analysis of extracellular vesicles as emerging theranostic nanoplatforms
Xing, Y., Cheng, Z., Wang, R., Lv, C., James, T. D., & Yu, F. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213506 · Cited by 67
Xu, J., Chen, P., Yu, C., Shi, Q., Wei, S., Li, Y., Qi, H., Cao, Q., Guo, C., Wu, X., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101868rrr · Cited by 58
A scalable platform for EPSC-induced MSC extracellular vesicles with therapeutic potential
Gong, S., Li, N., Peng, Q., Wang, F., Du, R., Zhang, B., Wang, J., Han, L., Zhang, Y., Ning, Z., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04507-y · Cited by 28
Metadata
- Authors
- Fang, S., Zhang, H., Wang, C., He, B., Liu, X., Meng, X., Peng, Y., Xu, Z., Fan, X., Wu, Z., Chen, D., Zheng, L., Zheng, S. G., & Fu, Q.
- Venue
- Journal of Extracellular Vesicles
- Publisher
- Wiley
- Published
- 2020-02-10
- Volume
- 9
- Issue
- 1
- Pages
- 1723260-1723260
- ISSN
- 2001-3078 (ISSN-L)
- OpenAlex
- W3006130458
- Cited by
- 234
- References
- 4
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell‐dominant allergic airway inflammation through delivery of miR‐146a‐5p. https://app.cochat.ai/papers/10.1080/20013078.2020.1723260
- The paper
- Fang, S., Zhang, H., Wang, C., He, B., Liu, X., Meng, X., Peng, Y., Xu, Z., Fan, X., Wu, Z., Chen, D., Zheng, L., Zheng, S. G., & Fu, Q. (2020). Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell‐dominant allergic airway inflammation through delivery of miR‐146a‐5p. Journal of Extracellular Vesicles. https://doi.org/10.1080/20013078.2020.1723260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.